BOT price action, page-439

The thing holding this company back is risk. Everyone on here feels pretty sure that given the throughbred credentials of the mgmt and top holders, the faith in the efficacy of the drug enough to submit it for expensive trials and the long, hard years they've dedicated to its development all indicate success. But what if the trial is a flop? Then kiss goodbye to half your capital.

So it's like a card counting player at the blackjack table who has tracked that the odds are now greatly in his favour. Does he load the bet up to $50K for the next hand? Logic says he should.